Yeah, but as @Miester points out, the guy doing the review was wearing sunglasses on a bright sunny day, so there's no way that review was accurate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025